4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-15-002911
CIK 0001369786operating
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:39 PM ET
Size
5.4 KB
Accession
0001181431-15-002911
Insider Transaction Report
Form 4
Logerfo Michael
Chief Legal Officer
Transactions
- Tax Payment
Common Stock
2015-02-18$27.22/sh−581$15,815→ 44,889 total
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:39 PM ET
- Size
- 5.4 KB